Stock Research: Camurus

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Camurus

OM:CAMX SE0007692850
67
  • Value
    83
  • Growth
    89
  • Safety
    Safety
    6
  • Combined
    67
  • Sentiment
    58
  • 360° View
    360° View
    67
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Camurus AB is a Sweden-based pharmaceutical and biotechnology company focused on specialty medicines for severe and chronic diseases. They operate in the pharmaceutical and biotechnology industries, developing products for opioid dependence, pain, cancer, and endocrine diseases. The company is based in Sweden and has legal entities in the US, Germany, UK, Finland, Norway, France, Australia, Spain, Denmark, Austria, and the Netherlands. In the last fiscal year, the company had a market cap of $4186 million, profits of $157 million, revenue of $169 million, and 256 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 67 (better than 67% compared with alternatives), overall professional sentiment and financial characteristics for the stock Camurus are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Camurus. The consolidated Growth Rank has a good rank of 89, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 89% of competitors in the same industry. The consolidated Safety Rank at 83 means that the company has a financing structure that is safer than 83% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 58, which means that professional investors are more optimistic about the stock than for 58% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 6, meaning that the share price of Camurus is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 94% of alternative stocks in the same industry. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
6 4 1 8
Growth
89 100 95 91
Safety
Safety
83 96 80 34
Sentiment
58 54 76 82
360° View
360° View
67 57 86 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
89 69 78 95
Opinions Change
21 50 72 50
Pro Holdings
n/a 45 53 64
Market Pulse
47 48 39 31
Sentiment
58 54 76 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
6 4 1 8
Growth
89 100 95 91
Safety Safety
83 96 80 34
Combined
67 69 72 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
27 14 6 25
Price vs. Earnings (P/E)
7 3 5 31
Price vs. Book (P/B)
3 3 5 12
Dividend Yield
1 1 1 1
Value
6 4 1 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
91 96 73 90
Profit Growth
96 98 100 78
Capital Growth
84 85 22 93
Stock Returns
33 86 100 20
Growth
89 100 95 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
90 92 90 77
Refinancing
44 25 27 36
Liquidity
92 100 79 8
Safety Safety
83 96 80 34

Similar Stocks

Discover high‑ranked alternatives to Camurus and broaden your portfolio horizons.

Ipsen

ENXTPA:IPN
Country: France
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

Embracer Group

OM:EMBRAC B
Country: Sweden
Industry: Interactive Home Entertainment
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.